Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The melanocortin type 4 receptor (MC4R) is a G protein-coupled receptor (GPCR) that plays a central role in regulating appetite, energy homeostasis, and body weight. It is highly expressed in the paraventricular nucleus of the hypothalamus and other brain regions involved in energy balance. Activation of MC4R decreases food intake and increases energy expenditure. Loss-of-function mutations in MC4R are the most common monogenic cause of human obesity. Drugs targeting MC4R are under development for anti-obesity therapy.
Gs protein activation, cAMP increase, regulation of Kir7.1 ion channels
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin type 4 receptor (MC4R).